The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
The Effector T Cells of Diabetic Subjects Are Resistant to Regulation via CD4+FOXP3+ Regulatory T Cells
Open accessAbstract
Defects in immune regulation have been implicated in the pathogenesis of diabetes in mouse and in man. In vitro assays using autologous regulatory (Treg) and responder effector (Teff) T cells have shown that suppression is impaired in diabetic subjects. In this study, we addressed whether the source of this defect is intrinsic to the Treg or Teff compartment of diabetic subjects. We first established that in type 1 diabetes (T1D) individuals, similar levels of impaired suppression were seen, irrespective of whether natural (nTreg) or adaptive Treg (aTreg) were present. Then using aTreg, we examined the ability of T1D aTreg to suppress Teff of healthy controls, as compared with the ability of control aTreg to suppress Teff of diabetic subjects. Taking this approach, we found that the aTregs from T1D subjects function normally in the presence of control Teff, and that the T1D Teff were resistant to suppression in the presence of control aTreg. This escape from regulation was seen with nTreg as well and was not transferred to control Teff coincubated with T1D Teff. Thus, the “defective regulation” in T1D is predominantly due to the resistance of responding T cells to Treg and is a characteristic intrinsic to the T1D Teff. This has implications with respect to pathogenic mechanisms, which underlie the development of disease and the target of therapies for T1D.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Role of Tumoral FOXP3 on Cell Proliferation, Migration, and Invasion in Gastric Cancer
Zhang, L., Xu, J., Zhang, X., Zhang, Y., Wang, L., Huang, X., & Xu, Z. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479442 · Cited by 4,088
Brunkow, M. E., Jeffery, E. W., Hjerrild, K. A., Paeper, B., Clark, L. B., Yasayko, S.-A., Wilkinson, J. E., Galas, D., Ziegler, S. F., & Ramsdell, F. (2001) · Nature Genetics · doi:10.1038/83784 · Cited by 2,636
Wildin, R. S., Ramsdell, F., Peake, J., Faravelli, F., Casanova, J.-L., Buist, N., Levy-Lahad, E., Mazzella, M., Goulet, O., Perroni, L., et al. (2001) · Nature Genetics · doi:10.1038/83707 · Cited by 1,922
Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25– T cells
R.Walker, M., Kasprowicz, D. J., Gersuk, V. H., Bènard, A., Van Landeghen, M., Buckner, J. H., & Ziegler, S. F. (2003) · Journal of Clinical Investigation · doi:10.1172/jci19441 · Cited by 1,245
Self-citationIn Vitro–expanded Antigen-specific Regulatory T Cells Suppress Autoimmune Diabetes
Tang, Q., Henriksen, K. J., Bi, M., Finger, E. B., Szot, G., Ye, J., Masteller, E. L., McDevitt, H., Bonyhadi, M., & Bluestone, J. A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040139 · Cited by 1,221
Defective Suppressor Function in CD4+CD25+ T-Cells From Patients With Type 1 Diabetes
Lindley, S., Dayan, C. M., Bishop, A., Roep, B. O., Peakman, M., & Tree, T. I. M. (2005) · Diabetes · doi:10.2337/diabetes.54.1.92 · Cited by 861
Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation
Korn, T., Reddy, J., Gao, W., Bettelli, E., Awasthi, A., Petersen, T. R., Bäckström, B. T., Sobel, R. A., Wucherpfennig, K. W., Strom, T. B., et al. (2007) · Nature Medicine · doi:10.1038/nm1564 · Cited by 811
TNF downmodulates the function of human CD4+CD25hi T-regulatory cells
Valencia, X., Stephens, G., Goldbach-Mansky, R., Wilson, M., Shevach, E. M., & Lipsky, P. E. (2006) · Blood · doi:10.1182/blood-2005-11-4567 · Cited by 781
Central Role of Defective Interleukin-2 Production in the Triggering of Islet Autoimmune Destruction
Tang, Q., Adams, J. Y., Penaranda, C., Melli, K., Piaggio, E., Sgouroudis, E., Piccirillo, C. A., Salomon, B. L., & Bluestone, J. A. (2008) · Immunity · doi:10.1016/j.immuni.2008.03.016 · Cited by 729
Toscano, M. A., Bianco, G. A., Ilarregui, J. M., Croci, D. O., Correale, J., Hernandez, J. D., Zwirner, N. W., Poirier, F., Riley, E. M., Baum, L. G., et al. (2007) · Nature Immunology · doi:10.1038/ni1482 · Cited by 653
Thornton, A. M., Donovan, E. E., Piccirillo, C. A., & Shevach, E. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.11.6519 · Cited by 560
Functional Defects and the Influence of Age on the Frequency of CD4+CD25+ T-Cells in Type 1 Diabetes
Brusko, T. M., Wasserfall, C. H., Clare-Salzler, M. J., Schatz, D. A., & Atkinson, M. A. (2005) · Diabetes · doi:10.2337/diabetes.54.5.1407 · Cited by 398
Coexpression of CD25 and CD27 identifies FoxP3+ regulatory T cells in inflamed synovia
Ruprecht, C. R., Gattorno, M., Ferlito, F., Gregorio, A., Martini, A., Lanzavecchia, A., & Sallusto, F. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050085 · Cited by 361
IL-21 Counteracts the Regulatory T Cell-Mediated Suppression of Human CD4+ T Lymphocytes
Peluso, I., Fantini, M. C., Fina, D., Caruso, R., Boirivant, M., MacDonald, T. T., Pallone, F., & Monteleone, G. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.2.732 · Cited by 285
No Alterations in the Frequency of FOXP3+ Regulatory T-Cells in Type 1 Diabetes
Brusko, T., Wasserfall, C., McGrail, K., Schatz, R., Viener, H. L., Schatz, D., Haller, M., Rockell, J., Gottlieb, P., Clare-Salzler, M., et al. (2007) · Diabetes · doi:10.2337/db06-1248 · Cited by 253
Dynamics of Pathogenic and Suppressor T Cells in Autoimmune Diabetes Development
Gregori, S., Giarratana, N., Smiroldo, S., & Adorini, L. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.8.4040 · Cited by 236
Allograft rejection mediated by memory T cells is resistant to regulation
Yang, J., Brook, M. O., Carvalho-Gaspar, M., Zhang, J., Ramon, H. E., Sayegh, M. H., Wood, K. J., Turka, L. A., & Jones, N. D. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704397104 · Cited by 214
You, S., Belghith, M., Cobbold, S., Alyanakian, M.-A., Gouarin, C., Barriot, S., Garcia, C., Waldmann, H., Bach, J.-F., & Chatenoud, L. (2005) · Diabetes · doi:10.2337/diabetes.54.5.1415 · Cited by 214
CD4+CD25high regulatory T cells in human autoimmune diabetes
Putnam, A. L., Vendrame, F., Dotta, F., & Gottlieb, P. A. (2005) · Journal of Autoimmunity · doi:10.1016/j.jaut.2004.11.004 · Cited by 205
Chowdary Venigalla, R. K., Tretter, T., Krienke, S., Max, R., Eckstein, V., Blank, N., Fiehn, C., Dick Ho, A., & Lorenz, H. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23556 · Cited by 196
Clough, L. E., Wang, C. J., Schmidt, E. M., Booth, G. C., Hou, T. Z., Ryan, G. A., & Walker, L. S. K. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.8.5393 · Cited by 116
A Mini Meta‐Analysis of Studies on CD4+CD25+ T cells in Human Type 1 Diabetes
Tree, T. I. M., Roep, B. O., & Peakman, M. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1375.002 · Cited by 77
Combination of rapamycin and IL-2 increases de novo induction of human CD4+CD25+FOXP3+ T cells
Long, S. A., & Buckner, J. H. (2008) · Journal of Autoimmunity · doi:10.1016/j.jaut.2007.12.012 · Cited by 72
Self-citationPeakman, M., Warnock, T. M., Vats, A., McNab, G. L., Underhill, J. A., Donaldson, P. T., & Vergani, D. (1994) · Diabetologia · doi:10.1007/s001250050087 · Cited by 33
Cited by
The PD‐1 pathway in tolerance and autoimmunity
Francisco, L. M., Sage, P. T., & Sharpe, A. H. (2010) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00923.x · Cited by 2,300
Genetics, pathogenesis and clinical interventions in type 1 diabetes
Bluestone, J. A., Herold, K., & Eisenbarth, G. (2010) · Nature · doi:10.1038/nature08933 · Cited by 1,265
Mechanisms of impaired regulation by CD4+CD25+FOXP3+ regulatory T cells in human autoimmune diseases
Buckner, J. H. (2010) · Nature Reviews Immunology · doi:10.1038/nri2889 · Cited by 789
Self-citationTreg cell-based therapies: challenges and perspectives
Raffin, C., Vo, L. T., & Bluestone, J. A. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-019-0232-6 · Cited by 720
Type 1 diabetes mellitus as a disease of the β-cell (do not blame the immune system?)
Roep, B. O., Thomaidou, S., van Tienhoven, R., & Zaldumbide, A. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-00443-4 · Cited by 623
Metadata
- Authors
- Schneider, A., Rieck, M., Sanda, S., Pihoker, C., Greenbaum, C., & Buckner, J. H.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-11
- Volume
- 181
- Issue
- 10
- Pages
- 7350-7355
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1509117621
- Cited by
- 301
- References
- 24
- FWCI
- 8.60
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.